MEDICAL-MANAGEMENT OF PERIPHERAL ARTERIAL-DISEASE

Patients with atherosclerotic peripheral arterial disease (PAD) of the lower extremities have an inadequate blood flow to exercising muscle. This results in a walking impairment due to intermittent claudication (exercise-induced cramping in the muscles of the lower extremities). Persons with PAD are at increased risk of cardiovascular events, with an excess mortality from strokes and myocardial infarction. The medica l treatment of patients with PAD is directed at intensive risk factor modification to decrease cardiovascular morbidity and mortality. A sec ond treatment goal is to improve exercise performance and functional c apacity. To this end, a limited number of drugs have been developed to improve claudication symptoms. In addition, the nonpharmacologic trea tment of claudication includes exercise rehabilitation. Previous studi es have shown that an exercise rehabilitation program results in signi ficant increases in treadmill peak walking time, peak oxygen consumpti on, and pain-free walking time. Patients also reported improved walkin g ability and functional status in the community setting. Therefore, o ptimal treatment of this patient population includes cardiovascular ri sk factor modification, selective use of claudication drugs, and exerc ise rehabilitation.